SRIT Healthcare - 2026 Company Profile, Team

About SRIT Healthcare

SRIT Healthcare is a publicly listed company based in Bengaluru (India) founded in 2020. It develops and manages healthcare software for hospitals and institutions worldwide efficiently. It operates on a B2B model. The company has 173 employees. Its Indian entity Srit India Limited reported revenue of ₹463 Cr. SRIT Healthcare offers products and services including AbHIS, RHES, Homing, Infinity PACS, and SiaH. Its focus areas include Health and Wellness Tech, Healthcare IT, Hospital Management and EMR Systems.

Company details

SRIT Healthcare designs, builds, and operates healthcare informatics systems, managing over 2000 medical and diagnostic institutions across the globe. Based in Bangalore, India, the company focuses on hospital management software, data migration, and analytics. It handles large-scale IT infrastructure and offers solutions for electronic health records and patient data management, enabling seamless operations for healthcare providers.

Headquarters Bengaluru, India
Employees 173
Stage Public
Sectors
Healthcare
Email
••••••••
Website srithealthcare.com
Legal Name Srit India Private Limited
Date of Incorporation 09 Sep, 1999
Jurisdiction Bangalore, Karnataka, India

Operational Areas

Healthcare → Hospitals & Clinical Care

Key Metrics

Market Cap
₹679 Cr
SRIT · NSE
Share Price
₹104.61
-0.92% today
Revenue
₹450 Cr
FY 2025-26 · +15.6% YoY
EBITDA
₹64.77 Cr
Margin 14.4%
Net Profit
₹43.26 Cr
FY 2025-26 · +28.5% YoY
P/E (TTM)
16.0x
P/B 1.6x
ROE
30.2%
ROCE 25.9%
Debt / Equity
0.37
Interest cover 24.5x
Employee Count
173

Associated legal entities of SRIT Healthcare

SRIT Healthcare is associated with 2 registered companies on The Company Check; the primary company is Srit India Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Srit India Limited Listed CIN U72200KA1999PLC025692	Active	09 Sep 1999	Bangalore, Karnataka	₹463 Cr	148	10	View details
Srit India Private Limited CIN U72200KA1999PTC025692		09 Sep 1999	Bangalore, Karnataka, India				View details

Products & Services of SRIT Healthcare

SRIT Healthcare offers a comprehensive portfolio of products and services, including AbHIS, RHES, Homing, Infinity PACS, and SiaH.

AbHIS

Hospital Software

Electronic health record system for hospital management and patient data.

RHES

Healthcare IT

System for managing hospital resources and operations efficiently.

Homing

Healthcare Platform

Tool for healthcare data integration and analytics purposes.

Infinity PACS

Medical Imaging

Platform for picture archiving and communication in healthcare.

SiaH

Health Management

Software for integrated hospital information systems and support.

Board of directors of Srit India Limited (SRIT Healthcare)

Srit India Limited is the primary company behind SRIT Healthcare. The board of Srit India Limited currently have 8 directors; the longest-serving is Nambiar Raghavan Madhusoodan, appointed in 1999. 13 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Nambiar Raghavan Madhusoodan DIN 00882507	Managing Director	15 Sep 1999	27 yrs 1 mo	Srit India Limited
Prasaktha Nambiar DIN 02389642	Whole-time director	01 Apr 2009	17 yrs 6 mo	Srit India Limited
Martin Poovakulam Chacko DIN 01747011	Whole-time director	06 Jul 2019	7 yrs 3 mo	Srit India Limited
Ramachandran Ravichandran DIN 10416022	Director	16 Feb 2024	2 yrs 8 mo	Srit India Limited
Karthick Varadarajan DIN 00220097	Director	28 Apr 2025	1 yr 6 mo	Srit India Limited
Rangan Thiyagarajan DIN 06906198	Director	28 Apr 2025	1 yr 6 mo	Srit India Limited
Thiruvengadam Ashok DIN 01971439	Additional Director	25 Jul 2025	1 yr 3 mo	Srit India Limited
Suresh Balachandran Menon DIN 11064181	Additional Director	10 Dec 2025	10 mo	Srit India Limited

IPO & Listings of SRIT Healthcare

SRIT Healthcare is a publicly listed company on the NSE with ticker symbol SRIT in India. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Listed onNSE: SRIT
Listed entitySrit India Limited

Financials of SRIT Healthcare

Exchange-reported figures of Srit India Limited, the listed company behind SRIT Healthcare (NSE: SRIT).

Financial Highlights

FY 2025-26 · Consolidated

Revenue

₹450 Cr

+15.6% YoY

EBITDA

₹64.77 Cr

+30.0% YoY

Profit After Tax

₹43.26 Cr

+28.5% YoY

Net Worth

₹193 Cr

+107.4% YoY

Total Assets

₹284 Cr

+14.2% YoY

Total Debt

₹44.81 Cr

-27.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income statement
Revenue	450	389	250	153	196	211
Revenue growth	+15.6%	+55.8%	+63.1%	-21.7%	-7.0%	-
EBITDA	64.77	49.81	26.83	23.15	13.83	15.70
EBITDA margin	+14.4%	+12.8%	+10.7%	+15.1%	+7.1%	+7.5%
Profit before tax	54.95	46.20	27.12	80.71	13.01	14.74
Net profit	43.26	33.66	19.10	73.29	6.49	10.45
Net profit margin	+9.6%	+8.7%	+7.6%	+47.8%	+3.3%	+5.0%
EPS (₹)	9.12	8.32	7.09	27.21	2.41	7.69
Balance sheet
Total assets	284	249	109	83.41	98.21	107
Net worth	193	93.17	80.56	61.44	22.03	20.42
Total debt	44.81	61.84	24.12	17.27	72.16	81.56
Cash & bank	21.69	18.90	24.29	3.46	2.05	4.08
Net working capital	168	94.91	63.69	54.39	47.04	28.96
Cash flow
Cash from operations	(12.10)	17.97	-	11.73	(2.62)	2.48
Cash from investing	(31.46)	(26.96)	-	(10.88)	(0.65)	(0.84)
Cash from financing	33.71	0.29	-	0.56	1.24	(1.42)

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Revenue	87.81	117	100	81.18	151
Revenue growth (YoY)	-42.0%	-	-	-	-
Other income	3.00	5.36	2.28	2.28	2.62
EBITDA	12.41	18.20	12.29	20.38	11.69
EBITDA margin	+14.1%	+15.6%	+12.2%	+25.1%	+7.7%
Depreciation	2.93	2.72	2.09	1.99	1.70
Interest	3.38	4.91	3.76	2.40	3.31
Profit before tax	9.10	15.93	8.72	18.27	9.30
Tax	2.30	3.67	0.02	5.95	1.71
Net profit	6.80	12.26	8.70	12.32	7.59
EPS (₹)	1.43	2.68	0.00	0.00	1.75

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income statement
Revenue	440	380	245	150	194	202
Revenue growth	+15.6%	+55.2%	+63.3%	-22.5%	-3.9%	-
EBITDA	63.09	49.30	27.85	21.37	11.24	8.58
EBITDA margin	+14.4%	+13.0%	+11.4%	+14.2%	+5.8%	+4.3%
Profit before tax	53.32	46.98	28.09	78.98	16.88	11.27
Net profit	40.80	34.78	20.61	72.52	11.37	8.31
Net profit margin	+9.3%	+9.2%	+8.4%	+48.3%	+5.9%	+4.1%
EPS (₹)	8.60	8.59	7.65	26.92	4.23	6.13
Balance sheet
Total assets	271	238	99.24	70.03	86.50	91.01
Net worth	184	86.81	74.54	53.93	15.31	8.77
Total debt	43.55	60.37	22.75	14.24	69.77	80.31
Cash & bank	19.75	17.44	23.34	1.78	0.39	2.98
Net working capital	158	84.93	51.84	41.25	35.43	13.95
Cash flow
Cash from operations	(17.53)	19.48	26.76	11.76	(5.60)	(0.59)
Cash from investing	(25.96)	(29.05)	(11.00)	(10.43)	0.24	(0.20)
Cash from financing	33.57	1.38	5.80	0.06	2.77	0.26

Particulars	Jun 2026	Mar 2026	Jun 2025
Revenue	86.52	114	149
Revenue growth (YoY)	-41.8%	-	-
Other income	2.97	5.32	2.61
Total expenses	74.15	96.09	136
EBITDA	12.37	17.82	12.29
EBITDA margin	+14.3%	+15.6%	+8.3%
Depreciation	2.85	2.60	1.58
Interest	3.34	4.87	3.26
Profit before tax	9.15	15.67	10.06
Tax	2.30	3.67	2.36

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 30 Oct 2026

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Revenue	87.81	117	100	81.18	151
Revenue growth (YoY)	-42.0%	-	-	-	-
Other income	3.00	5.36	2.28	2.28	2.62
EBITDA	12.41	18.20	12.29	20.38	11.69
EBITDA margin	+14.1%	+15.6%	+12.2%	+25.1%	+7.7%
Depreciation	2.93	2.72	2.09	1.99	1.70
Interest	3.38	4.91	3.76	2.40	3.31
Profit before tax	9.10	15.93	8.72	18.27	9.30
Tax	2.30	3.67	0.02	5.95	1.71
Net profit	6.80	12.26	8.70	12.32	7.59
EPS (₹)	1.43	2.68	0.00	0.00	1.75

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Revenue	450	389	250	153	196	211
Revenue growth	+15.6%	+55.8%	+63.1%	-21.7%	-7.0%	-
Other income	12.54	11.16	4.39	60.06	1.55	1.76
Total expenses	385	340	223	130	182	195
Employee cost	39.56	35.15	31.12	23.80	29.27	27.01
EBITDA	64.77	49.81	26.83	23.15	13.83	15.70
EBITDA margin	+14.4%	+12.8%	+10.7%	+15.1%	+7.1%	+7.5%
Depreciation	8.60	2.74	0.92	0.92	1.03	1.09
Interest	13.76	12.03	3.18	1.58	1.34	1.63
Profit before tax	54.95	46.20	27.12	80.71	13.01	14.74
Tax	11.66	12.59	8.29	7.40	6.46	4.21
Net profit	43.26	33.66	19.10	73.29	6.49	10.45
Net profit margin	+9.6%	+8.7%	+7.6%	+47.8%	+3.3%	+5.0%
EPS (₹)	9.12	8.32	7.09	27.21	2.41	7.69

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Equity & liabilities
Share capital	23.74	20.24	26.95	26.95	26.95	13.60
Reserves & surplus	170	72.93	53.61	34.49	(4.92)	6.82
Shareholders' funds (net worth)	193	93.17	80.56	61.44	22.03	20.42
Minority interest	0.57	0.58	1.22	1.49	1.50	1.20
Secured loans	18.29	5.46	10.30	14.72	12.71	8.42
Unsecured loans	26.52	56.38	13.82	2.55	59.45	73.14
Total debt	44.81	61.84	24.12	17.27	72.16	81.56
Total liabilities	284	249	109	83.41	98.21	107
Assets
Gross block	57.92	23.41	226	225	225	224
Net block	42.39	16.24	2.48	2.37	36.55	55.05
Capital work in progress	8.66	28.32	20.43	11.13	0.00	0.00
Investments	0.00	0.00	0.00	0.04	0.04	0.00
Inventories	0.00	0.00	48.70	34.04	23.06	17.92
Sundry debtors	235	197	318	288	272	167
Cash & bank balances	21.69	18.90	24.29	3.46	2.05	4.08
Loans & advances	242	127	11.22	15.21	19.46	4.95
Total current assets	498	343	402	340	316	194
Total current liabilities	330	248	339	286	269	165
Net working capital	168	94.91	63.69	54.39	47.04	28.96
Total assets	284	249	109	83.41	98.21	107

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Opening cash	15.44	24.14	-	2.05	4.08	3.86
Net cash from operating activities	(12.10)	17.97	-	11.73	(2.62)	2.48
Net cash from investing activities	(31.46)	(26.96)	-	(10.88)	(0.65)	(0.84)
Net cash from financing activities	33.71	0.29	-	0.56	1.24	(1.42)
Net change in cash	(9.85)	(8.71)	-	1.41	(2.03)	0.22
Closing cash	21.69	18.90	-	3.46	2.05	4.08

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Growth
Sales growth	+15.6%	+55.8%	+63.1%	-21.7%	-7.0%	-
EBITDA growth	+30.0%	+85.7%	+15.9%	+67.4%	-11.9%	-
PBT growth	+18.9%	+70.4%	-66.4%	+520.4%	-11.7%	+9997.0%
Net income growth	+28.5%	+76.2%	-73.9%	+1029.3%	-37.9%	-
Revenue CAGR (3Y)	+43.2%	+25.8%	+5.9%	-	-	-
EBITDA CAGR (3Y)	+40.9%	+53.3%	+19.6%	-	-	-
Profitability & leverage
Net income margin	+9.6%	+8.6%	+7.5%	+47.8%	+3.4%	+5.0%
Return on capital employed	+25.9%	+32.7%	+31.8%	+89.2%	+14.2%	+16.4%
Return on net worth	+30.2%	+38.6%	+26.5%	+164.0%	+31.1%	+73.0%
Debt / equity	0.37	0.49	0.29	1.79	0.00	0.00
Long-term debt / equity	0.13	0.11	0.02	0.09	0.00	0.00
Interest cover	24.50	25.56	12.27	7.11	10.47	11.16
Efficiency & per share
Fixed asset turnover	11.07	3.12	1.11	0.74	1.08	1.22
Inventory turnover	0.00	15.99	6.04	5.37	9.55	11.75
Debtors turnover	2.09	1.51	0.83	0.55	0.89	1.26
EPS (₹)	9.12	8.32	7.09	27.21	2.41	7.69
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	40.71	23.02	29.98	22.89	(4.33)	(23.17)

Particulars	Jun 2026	Mar 2026	Jun 2025
Revenue	86.52	114	149
Revenue growth (YoY)	-41.8%	-	-
Other income	2.97	5.32	2.61
Total expenses	74.15	96.09	136
EBITDA	12.37	17.82	12.29
EBITDA margin	+14.3%	+15.6%	+8.3%
Depreciation	2.85	2.60	1.58
Interest	3.34	4.87	3.26
Profit before tax	9.15	15.67	10.06
Tax	2.30	3.67	2.36

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Revenue	440	380	245	150	194	202
Revenue growth	+15.6%	+55.2%	+63.3%	-22.5%	-3.9%	-
Other income	12.44	11.66	5.02	59.97	7.10	4.53
Total expenses	376	331	217	129	182	193
Employee cost	37.29	9.61	10.84	7.34	12.70	13.56
EBITDA	63.09	49.30	27.85	21.37	11.24	8.58
EBITDA margin	+14.4%	+13.0%	+11.4%	+14.2%	+5.8%	+4.3%
Depreciation	8.02	2.29	0.32	0.25	0.24	0.27
Interest	14.19	11.69	4.46	2.11	1.22	1.57
Profit before tax	53.32	46.98	28.09	78.98	16.88	11.27
Tax	12.48	12.20	7.48	6.46	5.48	2.94
Net profit	40.80	34.78	20.61	72.52	11.37	8.31
Net profit margin	+9.3%	+9.2%	+8.4%	+48.3%	+5.9%	+4.1%
EPS (₹)	8.60	8.59	7.65	26.92	4.23	6.13

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Equity & liabilities
Share capital	23.74	20.24	26.95	26.95	26.95	13.60
Reserves & surplus	161	66.57	47.59	26.98	(11.64)	(4.83)
Shareholders' funds (net worth)	184	86.81	74.54	53.93	15.31	8.77
Secured loans	17.77	4.83	22.75	5.77	6.10	6.26
Unsecured loans	25.78	55.54	0.00	8.47	63.67	74.05
Total debt	43.55	60.37	22.75	14.24	69.77	80.31
Total liabilities	271	238	99.24	70.03	86.50	91.01
Assets
Gross block	54.78	21.53	216	184	212	211
Net block	41.54	16.20	1.36	0.84	34.97	53.12
Capital work in progress	8.66	28.32	22.09	11.13	0.00	0.00
Investments	0.02	0.02	1.27	1.31	1.31	1.66
Inventories	0.00	0.00	36.58	29.42	17.42	16.24
Sundry debtors	233	191	317	285	274	167
Cash & bank balances	19.75	17.44	23.34	1.78	0.39	2.98
Loans & advances	236	126	9.26	13.13	15.71	2.38
Total current assets	489	334	386	330	308	188
Total current liabilities	331	250	334	288	272	174
Net working capital	158	84.93	51.84	41.25	35.43	13.95
Total assets	271	238	99.24	70.03	86.50	91.01

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Opening cash	15.19	23.39	1.78	0.39	2.98	3.51
Net cash from operating activities	(17.53)	19.48	26.76	11.76	(5.60)	(0.59)
Net cash from investing activities	(25.96)	(29.05)	(11.00)	(10.43)	0.24	(0.20)
Net cash from financing activities	33.57	1.38	5.80	0.06	2.77	0.26
Net change in cash	(9.92)	(8.20)	21.56	1.39	(2.59)	(0.53)
Closing cash	19.75	17.44	23.34	1.78	0.39	2.98

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Growth
Sales growth	+15.6%	+55.2%	+63.3%	-22.5%	-3.9%	-
EBITDA growth	+28.0%	+77.0%	+30.3%	+90.1%	+31.0%	-
PBT growth	+13.5%	+67.3%	-64.4%	+367.9%	+49.8%	+9997.0%
Net income growth	+17.3%	+68.8%	-71.6%	+537.8%	+36.8%	-
Revenue CAGR (3Y)	+43.1%	+25.2%	+6.7%	-	-	-
EBITDA CAGR (3Y)	+43.5%	+63.7%	+48.1%	-	-	-
Profitability & leverage
Net income margin	+9.3%	+9.2%	+8.4%	+48.3%	+5.9%	+4.1%
Return on capital employed	+26.5%	+34.8%	+38.5%	+96.4%	+18.7%	+13.4%
Return on net worth	+30.1%	+43.1%	+32.1%	+179.2%	+56.1%	+61.0%
Debt / equity	0.38	0.52	0.29	2.38	0.00	0.00
Long-term debt / equity	0.13	0.24	0.18	0.36	0.00	0.00
Interest cover	25.77	24.87	16.20	9.99	11.09	18.89
Efficiency & per share
Fixed asset turnover	11.52	3.21	1.23	0.83	1.15	1.27
Inventory turnover	0.00	20.78	7.42	6.41	11.51	12.42
Debtors turnover	2.07	1.50	0.81	0.54	0.88	1.21
EPS (₹)	8.60	8.59	7.65	26.92	4.23	6.13
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	38.83	21.45	27.66	20.01	(6.91)	(31.88)

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as SRIT Healthcare (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Cloudnine	Maternity, childcare, and fertility services are delivered via hospital chains.	2007	Bengaluru, Karnataka, India	USD 204.87 M	USD 140.46 M	4,459
HCG	Chain of oncology hospitals	1989	Bengaluru, Karnataka, India	USD 36.59 M	USD 270.51 M	8,400
Medanta	Chain of multi-super specialty healthcare hospitals	2004	Gurugram, Haryana, India	USD 104.7 M	USD 461.72 M	12,240

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Srit Healthcare

SRIT India shares to list today; GMP signals 42% premium over issue price - The Economic Times

Economic Times • 24 days ago

SRIT India, Shah Investor's Home make positive D st debut; both stocks list at premium - BusinessToday

Business Today • 24 days ago

SRIT India shares hit 5% upper circuit after strong debut, jump 19% from IPO price. Should you buy, sell or hold? - The Economic Times

Economic Times • 24 days ago

SRIT India, Shah Investors shares make positive debut: What’s driving the rally? - The HinduBusinessLine

Thehindubusinessline • 24 days ago

SRIT India IPO subscribed over 125x on Day 3; GMP rises to 27%

Moneycontrol • 1 month ago

SRIT India IPO opens today: Should you apply or avoid? Check price band, reviews fresh GMP and more - BusinessToday

Business Today • 1 month ago

SRIT India Limited IPO Opens on September 28, 2026 - The Wire

The Wire • 1 month ago

BEL-led consortium to execute Kerala Fibre Optic Network project

Tele • 7 years ago

Premium access

Complete news archive for SRIT Healthcare

Full article history, source details, and older brand coverage require an active premium plan.

Full article archive
Source and publication date
Older coverage
Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SRIT Healthcare

When was SRIT Healthcare founded?

SRIT Healthcare was founded in 2020.

Where is SRIT Healthcare located?

SRIT Healthcare is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

How many employees does SRIT Healthcare have?

SRIT Healthcare has 173 employees.

What is the annual revenue of SRIT Healthcare?

The primary company behind SRIT Healthcare, Srit India Limited, reported revenue of ₹463 Cr for FY 2026, up 16% year on year.

What does SRIT Healthcare do?

SRIT Healthcare designs, builds, and operates healthcare informatics systems, managing over 2000 medical and diagnostic institutions across the globe. Based in Bangalore, India, the company focuses on hospital management software, data migration, and analytics. It handles large-scale IT infrastructure and offers solutions for electronic health records and patient data management, enabling seamless operations for healthcare providers.

What products or services does SRIT Healthcare offer?

SRIT Healthcare offers AbHIS, RHES, Homing, Infinity PACS, and SiaH.

Is SRIT Healthcare publicly traded?

Yes, SRIT Healthcare is publicly traded on NSE under the ticker symbol SRIT.

Which legal entities are associated with SRIT Healthcare?

SRIT Healthcare operates through Srit India Limited.

Who are the directors of SRIT Healthcare?

The legal entities of SRIT Healthcare currently have 10 directors, including Karthick Varadarajan, Thiruvengadam Ashok, Martin Poovakulam Chacko and others.